Azathioprine Withdrawn Phase 2 Trials for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01275274Retinoids in ANCA Small Vessel Vasculitis: Silencing Autoantigens